RecruitingDiabetesDiabetes Mellitus Type 2Type 2 Diabetes
Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)
Eligible age
65+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of The Brain Care Study is to investigate the prevalence of cognitive impairment in older adults with type 2 diabetes (T2D) and to evaluate the effectiveness of a multidomain intervention designed to prevent cognitive decline.
Sponsor: Steno Diabetes Center Copenhagen
You may qualify if…
- ✓ Age ≥ 65 years
- ✓ Diagnosis of Type 2 Diabetes (T2D)
- ✓ Patient at the outpatient clinic at either Bispebjerg Hospital, Rigshospitalet, or Steno Diabetes Center Copenhagen
- ✓ Speaks and understands Danish (required for the cognitive tests)
- ✓ Informed written consent
- ✓ Meets all the above inclusion criteria, and at least one of the following:
- ✓ 1. A diabetes-specific dementia score ≥ 7 (equivalent to a 40% increased risk of developing dementia within the next 10 years), and a SCIP or MoCA score ≥ 0.5 SD below the age- and education-adjusted norm
- ✓ 2. A SCIP or MoCA score ≥ 1 SD below the age- and education-adjusted norm
You may not qualify if…
- ✕ Diagnosis of dementia or prior referral to a dementia clinic
- ✕ Diagnosis of psychiatric, neurological, or other disorders that, in the investigator's opinion, hinder participation in cognitive screening, preclude compliance with the study protocol, or affect the evaluation of results
- ✕ Meets all the above exclusion criteria
- ✕ Participants whose cognitive MoCA screening indicates dementia will be excluded and advised to contact their physician
- ✕ Participants unwilling to engage in parts of the multidomain intervention will be excluded
Source: ClinicalTrials.gov · NCT07250789 · last updated 2025-11-26